Beneficial Effect of T-Type Calcium Channel Blockers on Endothelial Function in Patients with Essential Hypertension

Abstract

Endothelial function is impaired in essential hypertension. T-type but not L-type voltage-gated Ca2+ channels were detected in the vascular endothelium. The purpose of the present study was to clarify the role of T-type Ca2+ channels in endothelial function. We studied flow-mediated vasodilation (FMD) and sublingual nitroglycerin (NTG)-induced vasodilation in the brachial artery. Forty patients with essential hypertension were randomly assigned to treatment with efonidipine, a T- and L-type Ca2+ channel blocker, or with nifedipine, an L-type Ca2+ channel blocker. Twenty healthy normotensive individuals were included as a control group. In patients with essential hypertension, FMD was attenuated and NTG was similar that of compared to healthy controls. After 12 weeks, the decrease in mean blood pressure in the efonidipine and nifedipine groups were similar. The endothelial function index, a ratio of FMD/NTG, was significantly increased by efonidipine (73±24 to 94±20%) but unchanged by nifedipine. Urinary excretion 8-hydroxy-2′-deoxyguanosine (8-OHdG) and serum malondialdehyde-modified low-density lipoprotein (LDL) were decreased by efonidipine but unchanged by nifedipine. These results suggest that a T-type Ca2+ channel blocker, but not an L-type Ca2+ channel blocker, may improve vascular endothelial dysfunction in patients with essential hypertension via a reduction in oxidative stress.

References

  1. 1

    Ross A : Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.

    CAS  Article  Google Scholar 

  2. 2

    Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE : Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.

    CAS  PubMed  Article  Google Scholar 

  3. 3

    Moriguchi J, Itoh H, Harada S, et al: Low frequency regular exercise improves flow-mediated dilation of subjects with mild hypertension. Hypertens Res 2005; 28: 315–321.

    PubMed  Article  Google Scholar 

  4. 4

    Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G : Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30: 252–258.

    CAS  PubMed  Article  Google Scholar 

  5. 5

    Egashira K, Suzuki S, Hirooka Y, et al: Impaired endothelium-dependent vasodilation in large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension 1995; 25: 201–206.

    CAS  PubMed  Article  Google Scholar 

  6. 6

    Tarutani Y, Matsumoto T, Takashima H, Yamane T, Horie M : Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic response induced by bradykinin. Hypertens Res 2005; 28: 59–66.

    CAS  PubMed  Article  Google Scholar 

  7. 7

    Staessen JA, Li Y, Thijs L, Wang JG : Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res 2005; 28: 385–407.

    PubMed  Article  Google Scholar 

  8. 8

    Ghiadoni L, Magagna A, Versari D, et al: Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281–1286.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9

    Iwatsubo H, Nagano M, Sakai T, et al: Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 1997; 29: 286–290.

    CAS  PubMed  Article  Google Scholar 

  10. 10

    Hirooka Y, Imaizumi T, Masaki H, et al: Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992; 20: 175–180.

    CAS  PubMed  Article  Google Scholar 

  11. 11

    Millgard J, Hagg A, Sarabi M, Lind L : Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients. J Hum Hypertens 1998; 12: 511–516.

    CAS  PubMed  Article  Google Scholar 

  12. 12

    Taddei S, Virdis A, Ghiadoni L, et al: Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 2001; 37: 943–948.

    CAS  Article  Google Scholar 

  13. 13

    Wu S, Haynes J, Taylor JT, et al: Cav 3.1 (α1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation. Circ Res 2003; 93: 346–353.

    CAS  PubMed  Article  Google Scholar 

  14. 14

    Yazawa K, Ono K, Iijima T : Modulation by mibefradil of the histamine-induced Ca2+ entry in human aoritic endothelial cells. Jpn J Pharmacol 2002; 90: 125–130.

    CAS  PubMed  Article  Google Scholar 

  15. 15

    Nilius B, Prenen J, Kamouchi M, Viana F, Voets T, Droogmans G : Inhibition by mibefradil, a novel calcium antagonist, of Ca2+- and volume-activated Cl channels in macrovascular endothelial cells. Br J Pharmacol 1997; 121: 547–555.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16

    Masumiya H, Shijuku T, Tanaka H, Shigenobu K : Infibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur J Pharmacol 1998; 349: 351–357.

    CAS  PubMed  Article  Google Scholar 

  17. 17

    Oshima T, Ozono R, Yano Y, et al: Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 1219–1222.

    CAS  PubMed  Article  Google Scholar 

  18. 18

    Boulanger CM, Nakashima M, Olmos L, Joly G, Vanhoutte PM : Effects of the Ca2+ antagonist RO 40–5967 on endothelium-dependent responses of isolated arteries. J Cardiovasc Pharmacol 1994; 23: 869–876.

    CAS  PubMed  Article  Google Scholar 

  19. 19

    Boulanger CM, Desta B, Clozel JP, Vanhoutte PM : Chronic treatment with the Ca2+ channel inhibitor RO 40–5967 potentiates endothelium-dependent relaxations in the aorta of the hypertensive salt sensitive Dahl rat. Blood Press 1994; 3: 193–196.

    CAS  PubMed  Article  Google Scholar 

  20. 20

    Nomura S, Kanazawa S, Fukuhara S : Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 2002; 16: 539–547.

    CAS  PubMed  Article  Google Scholar 

  21. 21

    Hagiwara N, Irisawa H, Kameyama M : Contribution of two types of calcium currents to the pacemaker potentials of rabbit sinoatrial node cells. J Physiol 1988; 395: 233–253.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. 22

    Tseng GN, Boyden PA : Multiple types of Ca2+ currents in single canine Purkinje cells. Circ Res 1989; 65: 1735–1750.

    CAS  PubMed  Article  Google Scholar 

  23. 23

    Chen C, Lamping KG, Nuno DW, et al: Abnormal coronary function in mice deficient in α1H T-type Ca2+ channels. Science 2003; 302: 1416–1418.

    CAS  Article  Google Scholar 

  24. 24

    Vanbavel E, Sorop O, Andreasen D, Pfaffendorf M, Jensen BL : Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries. Am J Physiol 2002; 283: H2239–H2243.

    CAS  Google Scholar 

  25. 25

    Hornig B, Landmesser U, Kohler C : Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on the biovailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001; 103: 799–805.

    CAS  PubMed  Article  Google Scholar 

  26. 26

    Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K : Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346: 1954–1962.

    CAS  PubMed  Article  Google Scholar 

  27. 27

    Maggi E, Marchesi E, Ravette V, Martignoni A, Finardi G, Bellomo G : Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens 1995; 13: 129–138.

    CAS  PubMed  Article  Google Scholar 

  28. 28

    Mak TI, Boehme P, Weglicki WB : Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Circ Res 1992; 70: 1099–1103.

    CAS  PubMed  Article  Google Scholar 

  29. 29

    Umemoto S, Tanaka M, Kawahara S, et al: Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877–885.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30

    Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J : Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005; 28: 107–112.

    CAS  PubMed  Article  Google Scholar 

  31. 31

    Correti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39: 257–265.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Tetsuya Oshima.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Oshima, T., Ozono, R., Yano, Y. et al. Beneficial Effect of T-Type Calcium Channel Blockers on Endothelial Function in Patients with Essential Hypertension. Hypertens Res 28, 889–894 (2005). https://doi.org/10.1291/hypres.28.889

Download citation

Keywords

  • calcium
  • endothelium
  • nitroglycerin
  • vasodilation
  • ion channels

Further reading

Search

Quick links